• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION INTELLANAV STABLEPOINT OPEN-IRRIGATED; CATHETER, PERCUTANEOUS, CARDIAC ABLATION, FOR TREATMENT OF ATRIAL FIBRILLATION

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION INTELLANAV STABLEPOINT OPEN-IRRIGATED; CATHETER, PERCUTANEOUS, CARDIAC ABLATION, FOR TREATMENT OF ATRIAL FIBRILLATION Back to Search Results
Model Number M004IDERFS96200
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Chest Pain (1776); Dyspnea (1816); Inflammation (1932)
Event Date 01/08/2022
Event Type  Injury  
Manufacturer Narrative
It was indicated that the device will not be returned for evaluation.If there is any further relevant information obtained, a supplemental medwatch will be filed.
 
Event Description
(b)(6) study.It was reported that intellanav stablepoint ablation catheter was used in a ablation procedure on (b)(6) 2022.Two days following the index procedure on (b)(6) 2022, the patient experienced inflammation of the pericardium with symptoms including chest tightness & shortness of breath.The patients was given colchicine twice daily to 0.6 mg instead of just once a day.
 
Manufacturer Narrative
It was indicated that the device will not be returned for evaluation.If there is any further relevant information obtained, a supplemental medwatch will be filed.
 
Event Description
(b)(6) study.It was reported that intellanav stablepoint ablation catheter was used in a ablation procedure on (b)(6) 2022.Two days following the index procedure on (b)(6) 2022, the patient experienced inflammation of the pericardium with symptoms including chest tightness & shortness of breath.The patients was given colchicine twice daily to 0.6 mg instead of just once a day.
 
Event Description
Newton af clinical study.It was reported that intellanav stablepoint ablation catheter was used in a ablation procedure on (b)(6) 2022.Two days following the index procedure on (b)(6) 2022, the patient experienced inflammation of the pericardium with symptoms including chest tightness & shortness of breath.The patients was given colchicine twice daily to 0.6 mg instead of just once a day.
 
Manufacturer Narrative
The device has not been received for analysis; therefore, a failure analysis of the complaint device could not be completed.The manufacturing batch record review confirmed that the device met all material, assembly and performance specifications.Medical device info has been corrected.
 
Manufacturer Narrative
The device has not been received for analysis; therefore, a failure analysis of the complaint device could not be completed.The manufacturing batch record review confirmed that the device met all material, assembly and performance specifications.
 
Event Description
Pc053 newton af clinical study subject id: (b)(6).It was reported that intellanav stablepoint ablation catheter was used in a ablation procedure on (b)(6) 2022.Two days following the index procedure on (b)(6) 2022, the patient experienced inflammation of the pericardium with symptoms including chest tightness & shortness of breath.The patients was given colchicine twice daily to 0.6 mg instead of just once a day.It was further reported that the event was considered resolved on (b)(6) 2023.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
INTELLANAV STABLEPOINT OPEN-IRRIGATED
Type of Device
CATHETER, PERCUTANEOUS, CARDIAC ABLATION, FOR TREATMENT OF ATRIAL FIBRILLATION
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
302 parkway, global park
la aurora - heredia
CS  
Manufacturer Contact
timothy degroot
4100 hamline avenue north
dc a330
saint paul, MN 55112
6515826168
MDR Report Key13509525
MDR Text Key285674782
Report Number2134265-2022-01464
Device Sequence Number1
Product Code OAE
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Study,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 05/25/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/10/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date05/26/2023
Device Model NumberM004IDERFS96200
Device Lot Number0027388804
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received04/28/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured05/26/2021
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age66 YR
Patient SexFemale
Patient Weight41 KG
-
-